Elucidating New Drug Targets in Psoriasis by Gene Profiling: an Opportunity to Be Seized

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2015 May 21

PMID 25992377

Authors

Mark R Walter

Affiliations

Soon will be listed here.

References

Boyman O, Hefti H, Conrad C, Nickoloff B, Suter M, Nestle F . Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med. 2004; 199(5):731-6. PMC: 2213300. DOI: 10.1084/jem.20031482. View

Bissonnette R, Papp K, Maari C, Yao Y, Robbie G, White W . A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis. J Am Acad Dermatol. 2010; 62(3):427-36. DOI: 10.1016/j.jaad.2009.05.042. View

Lowes M, Suarez-Farinas M, Krueger J . Immunology of psoriasis. Annu Rev Immunol. 2014; 32:227-55. PMC: 4229247. DOI: 10.1146/annurev-immunol-032713-120225. View

Noda S, Krueger J, Guttman-Yassky E . The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immunol. 2014; 135(2):324-36. DOI: 10.1016/j.jaci.2014.11.015. View

Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R . IL-22 increases the innate immunity of tissues. Immunity. 2004; 21(2):241-54. DOI: 10.1016/j.immuni.2004.07.007. View

Harden J, Johnson-Huang L, Chamian M, Lee E, Pearce T, Leonardi C . Humanized anti-IFN-γ (HuZAF) in the treatment of psoriasis. J Allergy Clin Immunol. 2014; 135(2):553-6. DOI: 10.1016/j.jaci.2014.05.046. View

Mailman M, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R . The NCBI dbGaP database of genotypes and phenotypes. Nat Genet. 2007; 39(10):1181-6. PMC: 2031016. DOI: 10.1038/ng1007-1181. View

Perera G, Ainali C, Semenova E, Hundhausen C, Barinaga G, Kassen D . Integrative biology approach identifies cytokine targeting strategies for psoriasis. Sci Transl Med. 2014; 6(223):223ra22. DOI: 10.1126/scitranslmed.3007217. View

Parisi R, Symmons D, Griffiths C, Ashcroft D . Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2012; 133(2):377-85. DOI: 10.1038/jid.2012.339. View

10.

Davidovici B, Sattar N, Prinz J, Jorg P, Puig L, Emery P . Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010; 130(7):1785-96. DOI: 10.1038/jid.2010.103. View

11.

Baker B, Swain A, Fry L, Valdimarsson H . Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol. 1984; 110(5):555-64. DOI: 10.1111/j.1365-2133.1984.tb04678.x. View

12.

Paulin R, Courboulin A, Meloche J, Mainguy V, Dumas de la Roque E, Saksouk N . Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation. 2011; 123(11):1205-15. PMC: 3545712. DOI: 10.1161/CIRCULATIONAHA.110.963314. View

13.

Nawijn M, Alendar A, Berns A . For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer. 2010; 11(1):23-34. DOI: 10.1038/nrc2986. View

14.

Fox C, Hammerman P, Thompson C . The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med. 2005; 201(2):259-66. PMC: 2212793. DOI: 10.1084/jem.20042020. View

15.

Sa S, Valdez P, Wu J, Jung K, Zhong F, Hall L . The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol. 2007; 178(4):2229-40. DOI: 10.4049/jimmunol.178.4.2229. View

16.

Shen Y, Zhao Y, Zeng Y, Yan L, Chen B, Leng A . Inhibition of Pim-1 kinase ameliorates dextran sodium sulfate-induced colitis in mice. Dig Dis Sci. 2012; 57(7):1822-31. DOI: 10.1007/s10620-012-2106-7. View

17.

Gaffen S, Jain R, Garg A, Cua D . The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014; 14(9):585-600. PMC: 4281037. DOI: 10.1038/nri3707. View

18.

Wolk K, Witte E, Wallace E, Docke W, Kunz S, Asadullah K . IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006; 36(5):1309-23. DOI: 10.1002/eji.200535503. View

19.

Logsdon N, Deshpande A, Harris B, Rajashankar K, Walter M . Structural basis for receptor sharing and activation by interleukin-20 receptor-2 (IL-20R2) binding cytokines. Proc Natl Acad Sci U S A. 2012; 109(31):12704-9. PMC: 3412030. DOI: 10.1073/pnas.1117551109. View